0000950123-11-043087 FWP 2 20110502 20110502 CELANESE ACETATE LLC CELANESE AMERICAS LLC CELANESE CHEMICALS, INC. CELANESE FIBERS OPERATIONS LLC CELANESE GLOBAL RELOCATION LLC CELANESE INTERNATIONAL CORPORATION CELANESE LTD. CELTRAN, INC. CNA FUNDING LLC CNA HOLDINGS LLC KEP AMERICAS ENGINEERING PLASTICS, LLC TICONA FORTRON INC. TICONA LLC TICONA POLYMERS, INC. Celanese US Holdings LLC 0001314514 2673 201206848 DE 1231 FWP 34 333-173822-15 11801982 1601 W. LBJ FREEWAY DALLAS TX 75234 972-443-4000 1601 W. LBJ FREEWAY DALLAS TX 75234 BCP Crystal US Holdings Corp. 20050114 Celanese CORP 0001306830 2820 980420726 DE 1231 FWP 1601 W. LBJ FREEWAY DALLAS TX 75234 972-443-4000 1601 W. LBJ FREEWAY DALLAS TX 75234 Blackstone Crystal Holdings Capital Partners (Cayman) IV Ltd. 20041022 FWP 1 d81683fwfwp.htm FWP Free Writing Prospectus Filed pursuant to Rule 433 under the Securities Act (To the Preliminary Prospectus Registration Nos. 333-173822 Supplement dated May 2, 2011) and 333-173822-01 through 333-173822-15 [[Image Removed: (CELANESE LOGO)]] CELANESE US HOLDINGS LLC $400,000,000 57/8% Senior Notes due 2021 Term Sheet May 2, 2011 Issuer: Celanese US Holdings LLC Guarantors: Celanese Corporation and certain subsidiaries Principal Amount: $400,000,000 Title of Securities: 57/8% Senior Notes due 2021 (the “Notes”) Maturity: June 15, 2021 Offering Price: 100%, plus accrued interest from May 6, 2011, if any. Coupon 5.875% Yield to Maturity: 5.875% Interest Payment Dates: June 15 and December 15, commencing December 15, 2011 Record Dates: June 1 and December 1 Optional Redemption: Make-whole call at T+50 bps Joint Book-Running Managers: Merrill Lynch, Pierce, Fenner & Smith Incorporated Barclays Capital Inc. Deutsche Bank Securities Inc. HSBC Securities (USA) Inc. Morgan Stanley & Co. Incorporated RBS Securities Inc. Co-Managers: J.P. Morgan Securities LLC Citigroup Global Markets Inc. Trade Date: May 2, 2011 Settlement Date: May 6, 2011 (T+4) Distribution: Registered Offering -------------------------------------------------------------------------------- Net Proceeds: We estimate that the net proceeds of this offering, after deducting underwriting discounts and commission and estimated offering expenses from the sale of the notes will be approximately $392 million. CUSIP Number: 15089QAC8 ISIN Number: US15089QAC87 The issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting the Next-Generation EDGAR System on the SEC web site at www.sec.gov. Alternatively, the issuer or any underwriter will arrange to send you the prospectus if you request it by BofA Merrill Lynch, Attention: Syndicate Department, 4 World Financial Center, Mail Code: NY3-004-07-09, 250 Vesey Street, 7th Floor, New York, NY 10080, telephone: 800-294-1322, e-mail: dg.Prospectus_Distribution@baml.com. The information in this communication supersedes the information in the preliminary prospectus supplement to the extent it is inconsistent with such information. Before you invest, you should read the preliminary prospectus supplement (including the documents incorporated by reference therein) for more information concerning the Issuer and the Notes. Any disclaimers or other notices that may appear below are not applicable to this communication and should be disregarded. Such disclaimers or other notices were automatically generated as a result of this communication being sent via Bloomberg email or another communication system. 2